
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $835.5M | $951.2M | $1.1B | $1.1B | $1.2B | |
Revenue Growth (YoY) | -10.72% | 13.85% | 12.95% | 5.38% | 6.21% | |
Cost of Revenues | $290.2M | $316.6M | $356.8M | $363.1M | $391.8M | |
Gross Profit | $545.3M | $634.6M | $717.6M | $769.1M | $810.7M | |
Gross Profit Margin | 65.27% | 66.72% | 66.79% | 67.93% | 67.42% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $41.7M | $49.9M | $52.6M | $50.7M | $49.7M | |
Other Inc / (Exp) | $21.7M | $91.2M | $169M | $13.8M | $57.2M | |
Operating Expenses | $296.7M | $329.8M | $355M | $372.5M | $392.3M | |
Operating Income | $248.6M | $304.8M | $362.6M | $396.6M | $418.3M | |
Net Interest Expenses | $134.4M | $126.9M | $135.9M | $163.1M | $171.2M | |
EBT. Incl. Unusual Items | $135.9M | $269.1M | $395.7M | $247.2M | $304.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $135.9M | $269.1M | $395.7M | $247.2M | $304.3M | |
Minority Interest in Earnings | -$4.2M | -$7.6M | -$10.2M | -$10.2M | -$9.1M | |
Net Income to Common Excl Extra Items | $131.7M | $261.5M | $385.5M | $237M | $295.2M | |
Basic EPS (Cont. Ops) | $1.62 | $3.26 | $4.71 | $2.80 | $3.42 | |
Diluted EPS (Cont. Ops) | $1.62 | $3.26 | $4.71 | $2.80 | $3.42 | |
Weighted Average Basic Share | $75.5M | $77.3M | $79.9M | $81.3M | $83.6M | |
Weighted Average Diluted Share | $75.5M | $77.4M | $80.5M | $81.3M | $83.6M | |
EBITDA | $527.2M | $676.8M | $835.1M | $736.8M | $822.4M | |
EBIT | $272.2M | $396.8M | $532.7M | $415M | $479.8M | |
Revenue (Reported) | $835.5M | $951.2M | $1.1B | $1.1B | $1.2B | |
Operating Income (Reported) | $248.6M | $304.8M | $362.6M | $396.6M | $418.3M | |
Operating Income (Adjusted) | $272.2M | $396.8M | $532.7M | $415M | $479.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $218.2M | $256.8M | $273.1M | $291.3M | $309.2M | |
Revenue Growth (YoY) | -5.79% | 17.7% | 6.34% | 6.69% | 6.12% | |
Cost of Revenues | $78.7M | $86.8M | $87.8M | $95.7M | $104.4M | |
Gross Profit | $139.5M | $170M | $185.3M | $195.6M | $204.8M | |
Gross Profit Margin | 63.95% | 66.21% | 67.86% | 67.14% | 66.24% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.3M | $12.3M | $12.5M | $12M | $10.9M | |
Other Inc / (Exp) | $16.1M | $197K | $2.2M | $32K | $1.3M | |
Operating Expenses | $74.1M | $84M | $91.2M | $95.4M | $97.8M | |
Operating Income | $65.4M | $86M | $94.1M | $100.2M | $107M | |
Net Interest Expenses | $31.7M | $31.5M | $38.6M | $42.2M | $41.7M | |
EBT. Incl. Unusual Items | $49.7M | $54.7M | $57.7M | $58M | $66.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $49.7M | $54.7M | $57.7M | $58M | $66.6M | |
Minority Interest in Earnings | -$1.5M | -$2.7M | -$2.4M | -$1.3M | -$2.8M | |
Net Income to Common Excl Extra Items | $48.2M | $52M | $55.3M | $56.7M | $63.8M | |
Basic EPS (Cont. Ops) | $0.60 | $0.63 | $0.65 | $0.66 | $0.72 | |
Diluted EPS (Cont. Ops) | $0.60 | $0.63 | $0.65 | $0.66 | $0.72 | |
Weighted Average Basic Share | $76.8M | $78.4M | $81.1M | $82.6M | $85.5M | |
Weighted Average Diluted Share | $76.8M | $78.5M | $81.1M | $82.6M | $85.5M | |
EBITDA | $145.7M | $158M | $175.6M | $185.1M | $196M | |
EBIT | $81.8M | $86.3M | $97M | $101.7M | $109.1M | |
Revenue (Reported) | $218.2M | $256.8M | $273.1M | $291.3M | $309.2M | |
Operating Income (Reported) | $65.4M | $86M | $94.1M | $100.2M | $107M | |
Operating Income (Adjusted) | $81.8M | $86.3M | $97M | $101.7M | $109.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $822.1M | $989.8M | $1.1B | $1.2B | $1.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $295.4M | $324.7M | $357.8M | $371M | $400.5M | |
Gross Profit | $526.7M | $665.1M | $732.9M | $779.4M | $819.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $41.7M | $51.9M | $52.8M | $50.2M | $48.6M | |
Other Inc / (Exp) | $38.9M | $75.3M | $171M | $11.6M | $58.5M | |
Operating Expenses | $298.4M | $339.7M | $362.2M | $376.7M | $394.7M | |
Operating Income | $228.3M | $325.4M | $370.7M | $402.7M | $425.1M | |
Net Interest Expenses | $138M | $126.6M | $143.1M | $166.7M | $170.7M | |
EBT. Incl. Unusual Items | $129.2M | $274.1M | $398.7M | $247.5M | $312.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $129.2M | $274.1M | $398.7M | $247.5M | $312.9M | |
Minority Interest in Earnings | -$4M | -$8.8M | -$9.8M | -$9.1M | -$10.7M | |
Net Income to Common Excl Extra Items | $125.2M | $265.2M | $388.8M | $238.4M | $302.2M | |
Basic EPS (Cont. Ops) | $1.52 | $3.29 | $4.70 | $2.81 | $3.49 | |
Diluted EPS (Cont. Ops) | $1.52 | $3.28 | $4.69 | $2.81 | $3.49 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $525.8M | $689M | $852.7M | $746.3M | $833.3M | |
EBIT | $269.1M | $401.3M | $543.3M | $419.8M | $487.2M | |
Revenue (Reported) | $822.1M | $989.8M | $1.1B | $1.2B | $1.2B | |
Operating Income (Reported) | $228.3M | $325.4M | $370.7M | $402.7M | $425.1M | |
Operating Income (Adjusted) | $269.1M | $401.3M | $543.3M | $419.8M | $487.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $218.2M | $256.8M | $273.1M | $291.3M | $309.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $78.7M | $86.8M | $87.8M | $95.7M | $104.4M | |
Gross Profit | $139.5M | $170M | $185.3M | $195.6M | $204.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.3M | $12.3M | $12.5M | $12M | $10.9M | |
Other Inc / (Exp) | $16.1M | $197K | $2.2M | $32K | $1.3M | |
Operating Expenses | $74.1M | $84M | $91.2M | $95.4M | $97.8M | |
Operating Income | $65.4M | $86M | $94.1M | $100.2M | $107M | |
Net Interest Expenses | $31.7M | $31.5M | $38.6M | $42.2M | $41.7M | |
EBT. Incl. Unusual Items | $49.7M | $54.7M | $57.7M | $58M | $66.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $49.7M | $54.7M | $57.7M | $58M | $66.6M | |
Minority Interest in Earnings | -$1.5M | -$2.7M | -$2.4M | -$1.3M | -$2.8M | |
Net Income to Common Excl Extra Items | $48.2M | $52M | $55.3M | $56.7M | $63.8M | |
Basic EPS (Cont. Ops) | $0.60 | $0.63 | $0.65 | $0.66 | $0.72 | |
Diluted EPS (Cont. Ops) | $0.60 | $0.63 | $0.65 | $0.66 | $0.72 | |
Weighted Average Basic Share | $76.8M | $78.4M | $81.1M | $82.6M | $85.5M | |
Weighted Average Diluted Share | $76.8M | $78.5M | $81.1M | $82.6M | $85.5M | |
EBITDA | $145.7M | $158M | $175.6M | $185.1M | $196M | |
EBIT | $81.8M | $86.3M | $97M | $101.7M | $109.1M | |
Revenue (Reported) | $218.2M | $256.8M | $273.1M | $291.3M | $309.2M | |
Operating Income (Reported) | $65.4M | $86M | $94.1M | $100.2M | $107M | |
Operating Income (Adjusted) | $81.8M | $86.3M | $97M | $101.7M | $109.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $798.3M | $162.1M | $85.6M | $250.8M | $123.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $159.8M | $169M | $197.6M | $201.7M | $229.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $998M | $340.7M | $292.7M | $461.8M | $361.6M | |
Property Plant And Equipment | $143.4M | $140.6M | $140M | $93.8M | $92.4M | |
Long-Term Investments | $22.1M | $13M | $145.2M | $34.9M | $33.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $219M | $237.1M | $267.4M | $263.4M | $286.3M | |
Total Assets | $7.6B | $7.6B | $8.2B | $8.4B | $8.5B | |
Accounts Payable | $228.6M | $235.2M | $190.3M | $174.7M | $183.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $332.9M | $347M | $309.1M | $297.8M | $311.2M | |
Long-Term Debt | $4.3B | $4B | $4.3B | $4.6B | $4.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.9B | $4.7B | $5B | $5.2B | $5.1B | |
Common Stock | $160.8M | $160.8M | $160.6M | $160.7M | $160.7M | |
Other Common Equity Adj | -$5.6M | -$2M | $5.8M | $4.1M | $4.7M | |
Common Equity | $2.3B | $2.4B | $2.8B | $2.8B | $3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $222.3M | $296.3M | $258.4M | $262M | $252.8M | |
Total Equity | $2.7B | $2.9B | $3.2B | $3.2B | $3.4B | |
Total Liabilities and Equity | $7.6B | $7.6B | $8.2B | $8.4B | $8.5B | |
Cash and Short Terms | $798.3M | $162.1M | $85.6M | $250.8M | $123.4M | |
Total Debt | $4.3B | $4B | $4.3B | $4.6B | $4.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $779.9M | $157.9M | $99.4M | $95.9M | $109.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $161.2M | $183.5M | $200.5M | $207.7M | $220.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $981M | $350.9M | $309.4M | $312.8M | $338.6M | |
Property Plant And Equipment | $133.5M | $139.7M | $134M | $93.2M | $91.7M | |
Long-Term Investments | $12.1M | $13.2M | $143.5M | $33.7M | $32.9M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $227.4M | $245.6M | $257.1M | $259.1M | $296.5M | |
Total Assets | $7.7B | $7.7B | $8.3B | $8.3B | $8.6B | |
Accounts Payable | $254.5M | $233.8M | $196.1M | $185.6M | $197.4M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $360.3M | $346.5M | $314.9M | $308.3M | $328.9M | |
Long-Term Debt | $4.3B | $4B | $4.4B | $4.5B | $4.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.9B | $4.7B | $5.1B | $5.1B | $5.2B | |
Common Stock | $160.8M | $160.8M | $160.6M | $160.7M | $160.7M | |
Other Common Equity Adj | -$2.3M | $1.5M | $4.5M | $6.9M | $3.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $222.2M | $294.9M | $257.4M | $260.9M | $253.7M | |
Total Equity | $2.7B | $2.9B | $3.2B | $3.2B | $3.4B | |
Total Liabilities and Equity | $7.7B | $7.7B | $8.3B | $8.3B | $8.6B | |
Cash and Short Terms | $779.9M | $157.9M | $99.4M | $95.9M | $109.2M | |
Total Debt | $4.3B | $4B | $4.4B | $4.5B | $4.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $135.9M | $269.1M | $395.7M | $247.2M | $304.3M | |
Depreciation & Amoritzation | $255M | $280M | $302.4M | $321.8M | $342.6M | |
Stock-Based Compensation | -- | $13M | $13.7M | $14.3M | $16.4M | |
Change in Accounts Receivable | -$6M | $1.2M | -$12.1M | $3.5M | -$796K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $369.9M | $471.4M | $516.8M | $555.8M | $574.6M | |
Capital Expenditures | $501.9M | $440.5M | $416.7M | $311.1M | $246.8M | |
Cash Acquisitions | -$3.3M | -$3.1M | -$27.3M | -- | -- | |
Cash From Investing | -$368.4M | -$660.1M | -$786M | -$358.3M | -$446.8M | |
Dividends Paid (Ex Special Dividend) | -$324.6M | -$335.7M | -$347.3M | -$359.2M | -$371.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.5B | -- | $298.6M | $544.9M | $471.5M | |
Long-Term Debt Repaid | -$580.6M | -$277.6M | -$19.4M | -$333.5M | -$604.4M | |
Repurchase of Common Stock | -$4.1M | -$3M | -$4.9M | -$5M | -$6.7M | |
Other Financing Activities | -$21.2M | -$9.7M | -$43.8M | -$13M | -$45.2M | |
Cash From Financing | $661.7M | -$453M | $190.4M | -$33.8M | -$252.3M | |
Beginning Cash (CF) | $153.6M | $816.9M | $175.2M | $96.3M | $260M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $663.3M | -$641.7M | -$78.8M | $163.7M | -$124.6M | |
Ending Cash (CF) | $816.9M | $175.2M | $96.3M | $260M | $135.4M | |
Levered Free Cash Flow | -$132M | $30.8M | $100.1M | $244.7M | $327.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $48.1M | $64.5M | $63M | $114.7M | -- | |
Depreciation & Amoritzation | $67.7M | $74.5M | $79M | $85M | -- | |
Stock-Based Compensation | -- | $3.2M | $3.3M | $3.5M | -- | |
Change in Accounts Receivable | $3.8M | $1M | $3.5M | $16.8M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $132.1M | $157.5M | $149.3M | $169.7M | -- | |
Capital Expenditures | $133.9M | $109.5M | $79.1M | $60.4M | -- | |
Cash Acquisitions | -- | -$417K | -- | -- | -- | |
Cash From Investing | -$435.1M | -$211.9M | -$103.4M | -$185.7M | -- | |
Dividends Paid (Ex Special Dividend) | -$83.9M | -$85.8M | -$89.6M | -$92M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $317.2M | $69.2M | -- | |
Long-Term Debt Repaid | -$102.5M | -$16.9M | -$275.8M | -$20.3M | -- | |
Repurchase of Common Stock | -$8K | -$37K | -$66K | -$72K | -- | |
Other Financing Activities | -$2M | -$3.3M | -$2.1M | $3.4M | -- | |
Cash From Financing | -$188.5M | $70.8M | -$50.4M | $25M | -- | |
Beginning Cash (CF) | $808.4M | $178.2M | $107.3M | $104.8M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$491.5M | $16.4M | -$4.5M | $9M | -- | |
Ending Cash (CF) | $316.9M | $194.6M | $102.8M | $113.8M | -- | |
Levered Free Cash Flow | -$1.8M | $47.9M | $70.2M | $109.4M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $129.2M | $274.1M | $398.7M | $247.5M | $312.9M | |
Depreciation & Amoritzation | $256.7M | $287.8M | $309.4M | $326.5M | $346.1M | |
Stock-Based Compensation | -- | $16.8M | $14M | $14.4M | $16.1M | |
Change in Accounts Receivable | -$8.2M | -$10.9M | -$1.3M | $3.4M | $16.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $366.3M | $459.3M | $556.7M | $554M | $612.4M | |
Capital Expenditures | $463.3M | $441.8M | $408.2M | $298.4M | $242M | |
Cash Acquisitions | -$5.9M | -$458K | -$27.3M | -- | -- | |
Cash From Investing | -$291.4M | -$673.5M | -$798.6M | -$324.5M | -$561.7M | |
Dividends Paid (Ex Special Dividend) | -$326.6M | -$338.4M | -$351M | -$361.6M | -$375.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $358.6M | $969M | $32M | |
Long-Term Debt Repaid | -$627.9M | -$229.7M | -$19.4M | -$933.5M | -$5.6M | |
Repurchase of Common Stock | -$2.9M | -$4.8M | -$4.9M | -$5M | -$6.7M | |
Other Financing Activities | -$18M | -$11.7M | -$42.9M | -$32.9M | -$29.2M | |
Cash From Financing | -$285.9M | -$416.1M | $171M | -$232M | -$32.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$211M | -$630.3M | -$70.9M | -$2.5M | $17.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$97M | $17.5M | $148.5M | $255.6M | $370.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $97.8M | $119.2M | $120.7M | $172.7M | $66.6M | |
Depreciation & Amoritzation | $131.5M | $146.1M | $157.6M | $168.5M | $86.9M | |
Stock-Based Compensation | -- | $7M | $7.4M | $7.6M | $3.9M | |
Change in Accounts Receivable | $4.7M | -$10.3M | $3M | $16.3M | $16.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $247.2M | $260.5M | $292.3M | $310.9M | $179M | |
Capital Expenditures | $217.6M | $194.5M | $155.6M | $124.1M | $59M | |
Cash Acquisitions | -$2.7M | -$417K | -- | -- | -- | |
Cash From Investing | -$510M | -$300.1M | -$204.2M | -$252.6M | -$181.8M | |
Dividends Paid (Ex Special Dividend) | -$166.8M | -$171.5M | -$179M | -$183.9M | -$96M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $377.2M | $553.3M | $44.6M | |
Long-Term Debt Repaid | -$151.3M | -$17.8M | -$276.6M | -$621.1M | -$2M | |
Repurchase of Common Stock | -$2.8M | -$4.6M | -$4.7M | -$4.7M | -$4.6M | |
Other Financing Activities | -$3.5M | -$6.8M | -$4.7M | -$19M | -$6.5M | |
Cash From Financing | -$237.2M | $58.9M | -$81.7M | -$204.4M | -$10M | |
Beginning Cash (CF) | $1.6B | $353.4M | $203.6M | $364.8M | $135.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$500M | $19.4M | $6.4M | -$146.2M | -$12.7M | |
Ending Cash (CF) | $1.1B | $372.7M | $210M | $218.6M | $122.7M | |
Levered Free Cash Flow | $29.6M | $66M | $136.7M | $186.8M | $120M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.